{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:27:45Z","timestamp":1762504065665,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:00:00Z","timestamp":1688342400000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["phiro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physics and Imaging in Radiation Oncology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.phro.2023.100468","type":"journal-article","created":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T18:12:02Z","timestamp":1688580722000},"page":"100468","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Estimation of the risk of secondary cancer in rectum and bladder after radiation therapy for prostate cancer using a feasibility dose\u2013volume histogram"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8423-6509","authenticated-orcid":false,"given":"Takahiro","family":"Aoyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetoshi","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaro","family":"Koide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoki","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Tachibana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kojiro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kodaira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phro.2023.100468_b0005","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.radonc.2013.12.012","article-title":"PROBATE group of the GEC ESTRO. Second primary cancers after radiation for prostate cancer: a systematic review of the clinical data and impact of treatment technique","volume":"110","author":"Murray","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2023.100468_b0010","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1470-2045(13)70606-5","article-title":"Incidence of complications other than urinary incontinence or erectile dysfunction after radical prostatectomy or radiotherapy for prostate cancer: a population-based cohort study","volume":"15","author":"Nam","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.phro.2023.100468_b0015","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ijrobp.2009.02.011","article-title":"The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients","volume":"76","author":"Bhojani","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2023.100468_b0020","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.radonc.2010.09.012","article-title":"Analysis of second malignancies after modern radiotherapy versus prostatectomy for localized prostate cancer","volume":"98","author":"Huang","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2023.100468_b0025","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1078\/0939-3889-00242","article-title":"A simple dose\u2013response relationship for modeling secondary cancer incidence after radiotherapy","volume":"15","author":"Schneider","year":"2005","journal-title":"Z Med Phys"},{"key":"10.1016\/j.phro.2023.100468_b0030","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.ijrobp.2004.12.040","article-title":"Estimation of radiation-induced cancer from three-dimensional dose distributions: concept of organ equivalent dose","volume":"61","author":"Schneider","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2023.100468_b0035","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejmp.2017.03.011","article-title":"Risk of secondary cancers: bridging epidemiology and modeling","volume":"42","author":"Schneider","year":"2017","journal-title":"Phys Med"},{"key":"10.1016\/j.phro.2023.100468_b0040","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1742-4682-8-27","article-title":"Site-specific dose-response relationships for cancer induction from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy","volume":"8","author":"Schneider","year":"2011","journal-title":"Theor Biol Med Model"},{"key":"10.1016\/j.phro.2023.100468_b0045","doi-asserted-by":"crossref","unstructured":"Schneider U, Lomax A, Pemler P, Besserer J, Ross D, Lombriser N, et al. The impact of IMRT and proton radiotherapy on secondary cancer incidence. Strahlenther Onkol 2006;182:647\u201352.10. https:\/\/doi.org\/10.1007\/s00066-006-1534-8.","DOI":"10.1007\/s00066-006-1534-8"},{"key":"10.1016\/j.phro.2023.100468_b0050","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.3109\/0284186X.2015.1061691","article-title":"Risk of radiation-induced secondary rectal and bladder cancer following radiotherapy of prostate cancer","volume":"54","author":"Stokkev\u00e5g","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/j.phro.2023.100468_b0055","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/acm2.12972","article-title":"Estimation of secondary cancer risk after radiotherapy in high-risk prostate cancer patients with pelvic irradiation","volume":"21","author":"Haciislamoglu","year":"2020","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.phro.2023.100468_b0060","doi-asserted-by":"crossref","first-page":"5486","DOI":"10.1002\/mp.12500","article-title":"A method for a priori estimation of best feasible DVH for organs-at-risk: validation for head and neck VMAT planning","volume":"44","author":"Ahmed","year":"2017","journal-title":"Med Phys"},{"key":"10.1016\/j.phro.2023.100468_b0065","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/acm2.12165","article-title":"Assessment of PlanIQ Feasibility DVH for head and neck treatment planning","volume":"18","author":"Fried","year":"2017","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.phro.2023.100468_b0070","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejmp.2021.04.021","article-title":"Lung dose reduction in patients with stage III non-small-cell lung cancer using software that estimates patient-specific dose reduction feasibility","volume":"85","author":"Shimizu","year":"2021","journal-title":"Phys Med"},{"key":"10.1016\/j.phro.2023.100468_b0075","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.meddos.2021.03.013","article-title":"Impact of treatment planning quality assurance software on volumetric-modulated arc therapy plans for prostate cancer patients","volume":"46","author":"Sasaki","year":"2021","journal-title":"Med Dosim"},{"key":"10.1016\/j.phro.2023.100468_b0080","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/acm2.13233","article-title":"Analysis of prostate intensity- and volumetric-modulated arc radiation therapy planning quality with PlanIQTM","volume":"22","author":"Sasaki","year":"2021","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.phro.2023.100468_b0085","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.rpor.2019.08.003","article-title":"Evaluation of plan quality improvements in PlanIQ-guided autoplanning","volume":"24","author":"Perumal","year":"2019","journal-title":"Rep Pract Oncol Radiother"},{"key":"10.1016\/j.phro.2023.100468_b0090","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.636529","article-title":"Personalized treatment planning automation in prostate cancer radiation oncology: a comprehensive dosimetric study","volume":"11","author":"Cilla","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.phro.2023.100468_b0095","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S1470-2045(16)30102-4","article-title":"Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomisedrandomized, non-inferiority, phase 3 CHHiP trial","volume":"17","author":"Dearnaley","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.phro.2023.100468_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1667\/RR0763.1","article-title":"Solid cancer incidence in atomic bomb survivors: 1958\u20131998","volume":"168","author":"Preston","year":"2007","journal-title":"Radiat Res"},{"key":"10.1016\/j.phro.2023.100468_b0105","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1667\/RR3232","article-title":"Effect of recent changes in atomic bomb survivor dosimetry on cancer mortality risk estimates","volume":"162","author":"Preston","year":"2004","journal-title":"Radiat Res"},{"key":"10.1016\/j.phro.2023.100468_b0110","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00411-005-0016-1","article-title":"Radiation risk estimates after radiotherapy: application of the organ equivalent dose concept to plateau dose\u2013response relationships","volume":"44","author":"Schneider","year":"2005","journal-title":"Radiat Environ Biophys"},{"key":"10.1016\/j.phro.2023.100468_b0115","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00411-007-0151-y","article-title":"Cancer risk estimates from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy","volume":"47","author":"Schneider","year":"2008","journal-title":"Radiat Environ Biophys"},{"year":"1965","series-title":"Cellular Radiation Biology: a collection of works presented at the 18th Annual Symposium on Experimental Cancer Research 1964","author":"Gray","key":"10.1016\/j.phro.2023.100468_b0120"},{"key":"10.1016\/j.phro.2023.100468_b0125","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.ijrobp.2018.08.015","article-title":"A systematic post-QUANTEC review of tolerance doses for late toxicity after prostate cancer radiation therapy","volume":"102","author":"Olsson","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2023.100468_b0130","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1016\/j.ijrobp.2009.02.090","article-title":"Radiation dose-volume effects of the urinary bladder","volume":"76","author":"Viswanathan","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2023.100468_b0135","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1016\/S0140-6736(05)66695-0","article-title":"Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case-control study","volume":"365","author":"Sigurdson","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.phro.2023.100468_b0140","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.ijrobp.2009.09.055","article-title":"Increasing age and treatment modality are predictors for subsequent diagnosis of bladder cancer following prostate cancer diagnosis","volume":"78","author":"Singh","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Physics and Imaging in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405631623000593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405631623000593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:17:16Z","timestamp":1762503436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405631623000593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":28,"alternative-id":["S2405631623000593"],"URL":"https:\/\/doi.org\/10.1016\/j.phro.2023.100468","relation":{},"ISSN":["2405-6316"],"issn-type":[{"type":"print","value":"2405-6316"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estimation of the risk of secondary cancer in rectum and bladder after radiation therapy for prostate cancer using a feasibility dose\u2013volume histogram","name":"articletitle","label":"Article Title"},{"value":"Physics and Imaging in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phro.2023.100468","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of European Society of Radiotherapy & Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100468"}}